Abstract
Fifty patients were randomised in a double blind placebo controlled study to examine the influence of lorazepam (4 mg orally) before bone marrow aspiration and trephine biopsy. Assessment was made by a visual analogue linear pain scale compiled after the procedure and again 24 hours later. There was no difference in the pain recalled immediately after the procedure between the two groups, but the next day the patients who had received lorazepam showed amnesia with a 60% (p less than 0.01) reduction in the pain scale; 36% of the patients in this group had no recall of the procedure at all. There was no amnesic effect in the group taking placebo. Side effects were few, and it is concluded that lorazepam is a useful premedication agent before bone marrow biopsy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gale G. D., Galloon S., Porter W. R. Sublingual lorazepam: a better premedication? Br J Anaesth. 1983 Aug;55(8):761–765. doi: 10.1093/bja/55.8.761. [DOI] [PubMed] [Google Scholar]
- Laszlo J., Clark R. A., Hanson D. C., Tyson L., Crumpler L., Gralla R. Lorazepam in cancer patients treated with cisplatin: a drug having antiemetic, amnesic, and anxiolytic effects. J Clin Oncol. 1985 Jun;3(6):864–869. doi: 10.1200/JCO.1985.3.6.864. [DOI] [PubMed] [Google Scholar]
- Scott J., Huskisson E. C. Graphic representation of pain. Pain. 1976 Jun;2(2):175–184. [PubMed] [Google Scholar]
- Seymour R. A. The use of pain scales in assessing the efficacy of analgesics in post-operative dental pain. Eur J Clin Pharmacol. 1982;23(5):441–444. doi: 10.1007/BF00605995. [DOI] [PubMed] [Google Scholar]